Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Trends in US adults with overweight and obesity reporting being notified by doctors about body weight status, 1999-2016.

Hansen AR, Rustin C, Opoku ST, Shevatekar G, Jones J, Zhang J.

Nutr Metab Cardiovasc Dis. 2020 Jan 24. pii: S0939-4753(20)30018-1. doi: 10.1016/j.numecd.2020.01.002. [Epub ahead of print]

PMID:
32131986
2.

Cancer patients' experiences with immune checkpoint modulators: A qualitative study.

Ala-Leppilampi K, Baker NA, McKillop C, Butler MO, Siu LL, Spreafico A, Abdul Razak AR, Joshua AM, Hogg D, Bedard PL, Leighl N, Oza AM, Parsons JA, Hansen AR.

Cancer Med. 2020 Mar 2. doi: 10.1002/cam4.2940. [Epub ahead of print]

3.

Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis.

Nason GJ, Donahoe L, de Perrot M, Aditya I, Jewett MAS, Bedard PL, Hansen AR, Chung P, Warde P, Anson-Cartwright L, Sweet J, O'Malley M, Atenafu EG, Hamilton RJ.

Urology. 2020 Jan 28. pii: S0090-4295(20)30082-0. doi: 10.1016/j.urology.2019.12.032. [Epub ahead of print]

PMID:
32004556
4.

Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time.

Jiang DM, Hamilton RJ, Hansen AR.

Can Urol Assoc J. 2020 Feb;14(2):48-49. doi: 10.5489/cuaj.6407. No abstract available.

5.

Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.

Savard MF, Wells JC, Graham J, Dudani S, Steinharter JA, McGregor BA, Donskov F, Bjarnason GA, Vaishampayan UN, Hansen AR, Iafolla MAJ, Zanotti G, Huynh L, Chang R, Duh MS, Heng DYC.

Oncologist. 2020 Jan 23. doi: 10.1634/theoncologist.2019-0605. [Epub ahead of print]

6.

Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma.

Wells JC, Graham J, Beuselinck B, Bjarnason GA, Donskov F, Hansen AR, McKay RR, Vaishampayan U, De Velasco G, Duh MS, Huynh L, Nguyen C, Zanotti G, Ramaswamy K, Choueiri TK, Heng DYC.

Clin Genitourin Cancer. 2019 Dec 13. pii: S1558-7673(19)30380-5. doi: 10.1016/j.clgc.2019.12.007. [Epub ahead of print]

PMID:
31926879
7.

Hearing in Schoolchildren After Neonatal Exposure to a High-Dose Gentamicin Regimen.

Hemmingsen D, Mikalsen C, Hansen AR, Fjalstad JW, Stenklev NC, Klingenberg C.

Pediatrics. 2020 Feb;145(2). pii: e20192373. doi: 10.1542/peds.2019-2373. Epub 2020 Jan 8.

PMID:
31915192
8.

Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.

Hansen AR, Ala-Leppilampi K, McKillop C, Siu LL, Bedard PL, Abdul Razak AR, Spreafico A, Sridhar SS, Leighl N, Butler MO, Hogg D, Sacher A, Oza AM, Al-Agha R, Maurice C, Chan CT, Shapera S, Feld JJ, Nisenbaum R, Webster K, Cella D, Parsons J.

Cancer. 2020 Apr 1;126(7):1550-1558. doi: 10.1002/cncr.32692. Epub 2020 Jan 8.

PMID:
31914209
9.

Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.

de Almeida JR, Noel CW, Veigas M, Martino R, Chepeha DB, Bratman SV, Goldstein DP, Hansen AR, Yu E, Metser U, Weinreb I, Perez-Ordonez B, Xu W, Kim J.

BMJ Open. 2019 Dec 30;9(12):e035431. doi: 10.1136/bmjopen-2019-035431.

10.

Porous high amylose rice starch modified by amyloglucosidase and maltogenic α-amylase.

Keeratiburana T, Hansen AR, Soontaranon S, Blennow A, Tongta S.

Carbohydr Polym. 2020 Feb 15;230:115611. doi: 10.1016/j.carbpol.2019.115611. Epub 2019 Nov 14.

PMID:
31887905
11.

Structure and Optimization of Checkpoint Inhibitors.

Picardo SL, Doi J, Hansen AR.

Cancers (Basel). 2019 Dec 21;12(1). pii: E38. doi: 10.3390/cancers12010038. Review.

12.

Porous rice starch produced by combined ultrasound-assisted ice recrystallization and enzymatic hydrolysis.

Keeratiburana T, Hansen AR, Soontaranon S, Tongta S, Blennow A.

Int J Biol Macromol. 2020 Feb 15;145:100-107. doi: 10.1016/j.ijbiomac.2019.12.144. Epub 2019 Dec 18.

PMID:
31862366
13.

Neurologic Injury and Brain Growth in the Setting of Long-Gap Esophageal Atresia Perioperative Critical Care: A Pilot Study.

Rudisill SS, Wang JT, Jaimes C, Mongerson CRL, Hansen AR, Jennings RW, Bajic D.

Brain Sci. 2019 Dec 17;9(12). pii: E383. doi: 10.3390/brainsci9120383.

14.

High Prevalence of Staphylococcus aureus Enterotoxin Gene Cluster Superantigens in Cystic Fibrosis Clinical Isolates.

Fischer AJ, Kilgore SH, Singh SB, Allen PD, Hansen AR, Limoli DH, Schlievert PM.

Genes (Basel). 2019 Dec 12;10(12). pii: E1036. doi: 10.3390/genes10121036.

15.

Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.

Stephens RF, Noel CW, Su JS, Xu W, Krahn M, Monteiro E, Goldstein DP, Giuliani M, Hansen AR, de Almeida JR.

Head Neck. 2020 Mar;42(3):513-521. doi: 10.1002/hed.26031. Epub 2019 Nov 24.

PMID:
31762112
16.

Rising incidence of late-stage head and neck cancer in the United States.

Thompson-Harvey A, Yetukuri M, Hansen AR, Simpson MC, Adjei Boakye E, Varvares MA, Osazuwa-Peters N.

Cancer. 2020 Mar 1;126(5):1090-1101. doi: 10.1002/cncr.32583. Epub 2019 Nov 13.

PMID:
31722124
17.

Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma.

Mesia R, Bossi P, Hansen AR, Hsieh CY, Licitra LF, Tan EH, Chen P, Miller J, Siu LL, Haddad RI.

Eur J Cancer. 2019 Dec;123:138-145. doi: 10.1016/j.ejca.2019.10.002. Epub 2019 Nov 4.

18.

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M, Penel N, Hansen AR, Piha-Paul SA, Doi T, Gao B, Chung HC, Lopez-Martin J, Bang YJ, Frommer RS, Shah M, Ghori R, Joe AK, Pruitt SK, Diaz LA Jr.

J Clin Oncol. 2020 Jan 1;38(1):1-10. doi: 10.1200/JCO.19.02105. Epub 2019 Nov 4.

PMID:
31682550
19.

Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts.

Iafolla MAJ, Picardo S, Aung K, Hansen AR.

PLoS One. 2019 Oct 22;14(10):e0222359. doi: 10.1371/journal.pone.0222359. eCollection 2019.

20.

The PD-1/PD-L1 pathway in advanced prostate cancer-have we milked this cow?

Picardo SL, Hansen AR.

Ann Transl Med. 2019 Jul;7(14):346. doi: 10.21037/atm.2019.05.86. No abstract available.

21.

Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Oliva M, Huang SH, Xu W, Su J, Hansen AR, Bratman SV, Ringash J, Jang R, Cho J, Bayley A, Hope AJ, Chen E, Giuliani M, Waldron J, Weinreb I, Perez-Ordonez B, Chepeha D, Kim J, O Sullivan B, Siu LL, Spreafico A.

Eur J Cancer. 2019 Sep;118:112-120. doi: 10.1016/j.ejca.2019.06.019. Epub 2019 Jul 19.

PMID:
31330486
22.

Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.

Chung P, O'Malley ME, Jewett MAS, Bedard PL, Panzarella T, Sturgeon J, Moore MJ, Hamilton R, Hansen AR, Anson-Cartwright L, Gospodarowicz M, Warde P.

Eur Urol Oncol. 2019 Jul;2(4):437-442. doi: 10.1016/j.euo.2018.08.031. Epub 2018 Oct 2.

PMID:
31277780
23.

Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.

Green BJ, Nguyen V, Atenafu E, Weeber P, Duong BTV, Thiagalingam P, Labib M, Mohamadi RM, Hansen AR, Joshua AM, Kelley SO.

Anal Chem. 2019 Aug 6;91(15):9348-9355. doi: 10.1021/acs.analchem.9b01697. Epub 2019 Jul 8.

PMID:
31264404
24.

The microbiome and cancer for clinicians.

Picardo SL, Coburn B, Hansen AR.

Crit Rev Oncol Hematol. 2019 Sep;141:1-12. doi: 10.1016/j.critrevonc.2019.06.004. Epub 2019 Jun 8. Review.

PMID:
31202124
25.

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.

O'Kane GM, Ezzat S, Joshua AM, Bourdeau I, Leibowitz-Amit R, Olney HJ, Krzyzanowska M, Reuther D, Chin S, Wang L, Brooks K, Hansen AR, Asa SL, Knox JJ.

Br J Cancer. 2019 Jun;120(12):1113-1119. doi: 10.1038/s41416-019-0474-x. Epub 2019 May 20.

PMID:
31105270
26.

Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Stukalin I, Wells JC, Graham J, Yuasa T, Beuselinck B, Kollmansberger C, Ernst DS, Agarwal N, Le T, Donskov F, Hansen AR, Bjarnason GA, Srinivas S, Wood LA, Alva AS, Kanesvaran R, Fu SYF, Davis ID, Choueiri TK, Heng DYC.

Curr Oncol. 2019 Apr;26(2):e175-e179. doi: 10.3747/co.26.4595. Epub 2019 Apr 1.

27.

Pet ownership and the risk of dying from lung cancer, findings from an 18 year follow-up of a US national cohort.

Adhikari A, Jacob NK, Hansen AR, Wei Y, Snook K, Liu F, Zhang J.

Environ Res. 2019 Jun;173:379-386. doi: 10.1016/j.envres.2019.01.037. Epub 2019 Feb 25.

PMID:
30954911
28.

Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.

Billfalk-Kelly A, Yu E, Su J, O'Sullivan B, Waldron J, Ringash J, Bartlett E, Perez-Ordonez B, Weinreb I, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Hansen AR, de Almeida J, Tong L, Xu W, Huang SH.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1017-1027. doi: 10.1016/j.ijrobp.2019.03.047. Epub 2019 Apr 4.

PMID:
30953712
29.

Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Hansen AR, Tannock IF, Templeton A, Chen E, Evans A, Knox J, Prawira A, Sridhar SS, Tan S, Vera-Badillo F, Wang L, Wouters BG, Joshua AM.

Oncologist. 2019 Sep;24(9):1188-1194. doi: 10.1634/theoncologist.2018-0621. Epub 2019 Apr 5.

30.

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).

Clouthier DL, Lien SC, Yang SYC, Nguyen LT, Manem VSK, Gray D, Ryczko M, Razak ARA, Lewin J, Lheureux S, Colombo I, Bedard PL, Cescon D, Spreafico A, Butler MO, Hansen AR, Jang RW, Ghai S, Weinreb I, Sotov V, Gadalla R, Noamani B, Guo M, Elston S, Giesler A, Hakgor S, Jiang H, McGaha T, Brooks DG, Haibe-Kains B, Pugh TJ, Ohashi PS, Siu LL.

J Immunother Cancer. 2019 Mar 13;7(1):72. doi: 10.1186/s40425-019-0541-0.

31.

Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era.

Tan T, Rheaume M, Wang L, Chow H, Spreafico A, Hansen AR, Razak ARA, Siu LL, Bedard PL.

Oncologist. 2019 Jul;24(7):e518-e525. doi: 10.1634/theoncologist.2018-0808. Epub 2019 Mar 4.

32.

Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.

Shepshelovich D, McDonald K, Spreafico A, Razak ARA, Bedard PL, Siu LL, Minasian L, Hansen AR.

Oncologist. 2019 Apr;24(4):e146-e148. doi: 10.1634/theoncologist.2018-0332. Epub 2019 Feb 6.

33.

Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.

Lewin J, Dufort P, Halankar J, O'Malley M, Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, Nayan M, Leão R, Warde P, Chung P, Anson Cartwright L, Sweet J, Hansen AR, Metser U, Bedard PL.

JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.18.00004.

34.

The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.

Bjarnason GA, Knox JJ, Kollmannsberger CK, Soulieres D, Ernst DS, Zalewski P, Canil CM, Winquist E, Hotte SJ, North SA, Heng DYC, Macfarlane RJ, Venner PM, Kapoor A, Hansen AR, Eigl BJ, Czaykowski P, Boyd B, Wang L, Basappa NS.

Eur J Cancer. 2019 Feb;108:69-77. doi: 10.1016/j.ejca.2018.12.006. Epub 2019 Jan 14.

35.

Notice of Retraction and Replacement. Snook et al. Change in percentages of adults with overweight or obesity trying to lose weight, 1988-2014. JAMA. 2017;317(9):971-973.

Snook KR, Hansen AR, Duke CH, Hackney AA, Zhang J.

JAMA. 2018 Dec 18;320(23):2485-2486. doi: 10.1001/jama.2018.18136. No abstract available.

PMID:
30561485
36.

Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials.

Kanjanapan Y, Day D, Butler MO, Wang L, Joshua AM, Hogg D, Leighl NB, Razak ARA, Hansen AR, Boujos S, Chappell M, Chow K, Sherwin B, Stayner LA, Soultani L, Zambrana A, Siu LL, Bedard PL, Spreafico A.

Eur J Cancer. 2019 Jan;107:1-7. doi: 10.1016/j.ejca.2018.10.017. Epub 2018 Dec 7.

PMID:
30529898
37.

Disease Intervention Specialist Education for the Future: An Analysis of Public Health Curricula.

Mase WA, Hansen AR, Smallwood SW, Shah G, Peden AH, Mulherin T, Bender K.

Public Health Rep. 2018 Nov;133(6):738-748. doi: 10.1177/0033354918792014. Epub 2018 Oct 10.

38.

Increased oxidation of RNA despite reduced mitochondrial respiration after chronic electroconvulsive stimulation of rat brain tissue.

Nielsen B, Cejvanovic V, Wörtwein G, Hansen AR, Marstal KK, Weimann A, Bjerring PN, Dela F, Poulsen HE, Jørgensen MB.

Neurosci Lett. 2019 Jan 18;690:1-5. doi: 10.1016/j.neulet.2018.09.061. Epub 2018 Oct 1.

PMID:
30287304
39.

Striving to Meet Healthy People 2020 Objectives: Trend Analysis of Maternal Smoking.

Hansen AR, Akomolafe TO, McGalliard Z, Belle-Isle L, Zhang J.

Public Health Rep. 2018 Nov;133(6):644-649. doi: 10.1177/0033354918793120. Epub 2018 Oct 2.

40.

Evaluating the Prediction of Breast Cancer Survival Using Lymph Node Ratio.

Hung M, Xu J, Nielson D, Bounsanga J, Gu Y, Hansen AR, Voss MW.

J Breast Cancer. 2018 Sep;21(3):315-320. doi: 10.4048/jbc.2018.21.e35. Epub 2018 Aug 28.

41.

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study.

Hansen AR, Massard C, Ott PA, Haas NB, Lopez JS, Ejadi S, Wallmark JM, Keam B, Delord JP, Aggarwal R, Gould M, Yang P, Keefe SM, Piha-Paul SA.

Ann Oncol. 2018 Aug 1;29(8):1807-1813. doi: 10.1093/annonc/mdy232.

42.

Special Supplemental Nutrition Program for Women, Infants, and Children Program, a Social Experiment on Effective Strategies to Prevent Severe Obesity Among Preschool Children.

Zhang J, Hansen AR.

JAMA Pediatr. 2018 Jul 1;172(7):704. doi: 10.1001/jamapediatrics.2018.1019. No abstract available.

PMID:
29813160
43.

Report on the Current Inventory of the Toolbox for Plant Cell Wall Analysis: Proteinaceous and Small Molecular Probes.

Rydahl MG, Hansen AR, Kračun SK, Mravec J.

Front Plant Sci. 2018 May 3;9:581. doi: 10.3389/fpls.2018.00581. eCollection 2018. Review.

44.

Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.

Lewin J, Soltan Ghoraie L, Bedard PL, Hamilton RJ, Chung P, Moore M, Jewett MAS, Anson-Cartwright L, Virtanen C, Winegarden N, Tsao J, Warde P, Sweet J, Haibe-Kains B, Hansen AR.

BJU Int. 2018 Nov;122(5):814-822. doi: 10.1111/bju.14372. Epub 2018 May 31.

45.

A Qualitative Study to Assess Barber Perceptions of the Feasibility of the Employer as a Health Advisor for Obesity Prevention.

Roy S, Hansen AR, Ross L, Larson R.

Am J Mens Health. 2018 Sep;12(5):1450-1462. doi: 10.1177/1557988318768586. Epub 2018 Apr 16.

46.

Trends in Smoking and Smoking Cessation During Pregnancy from 1985 to 2014, Racial and Ethnic Disparity Observed from Multiple National Surveys.

Li H, Hansen AR, McGalliard Z, Gover L, Yan F, Zhang J.

Matern Child Health J. 2018 May;22(5):685-693. doi: 10.1007/s10995-018-2437-x.

PMID:
29397497
47.

Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.

Lieng H, Warde P, Bedard P, Hamilton RJ, Hansen AR, Jewett MAS, O'malley M, Sweet J, Chung P.

Can Urol Assoc J. 2018 Feb;12(2):59-66. doi: 10.5489/cuaj.4531. Epub 2017 Dec 1. Review.

48.

Actual body weight or perceived body weight? Comment on 'childhood obesity and school absenteeism: a systematic review and meta-analysis'.

Zhang J, Hansen AR, Duncan DT, Li Y, Tedders SH.

Obes Rev. 2018 Mar;19(3):430-431. doi: 10.1111/obr.12651. Epub 2017 Dec 15. No abstract available.

PMID:
29243337
49.

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.

Prawira A, Oosting SF, Chen TW, Delos Santos KA, Saluja R, Wang L, Siu LL, Chan KKW, Hansen AR.

Br J Cancer. 2017 Dec 5;117(12):1743-1752. doi: 10.1038/bjc.2017.357. Epub 2017 Oct 24. Review.

50.

Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review.

Khoja L, Day D, Wei-Wu Chen T, Siu LL, Hansen AR.

Ann Oncol. 2017 Oct 1;28(10):2377-2385. doi: 10.1093/annonc/mdx286. Review.

Supplemental Content

Loading ...
Support Center